{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:48:59Z","timestamp":1789012139915,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.bbmt.2018.12.070","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T20:24:07Z","timestamp":1544905447000},"page":"771-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5258-5720","authenticated-orcid":false,"given":"Corinna","family":"La Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Longmate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan Raj","family":"Lingaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Kaltcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Hardwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Aldoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don J.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.12.070_bib0001","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V98.3.754","article-title":"Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers","volume":"98","author":"Gamadia","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0002","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20160758","article-title":"Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection","volume":"214","author":"Gordon","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0005","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0006","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood-2015-03-631853","article-title":"CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR\u03b2 repertoire","volume":"125","author":"Suessmuth","year":"2015","journal-title":"Blood"},{"issue":"Suppl 4)","key":"10.1016\/j.bbmt.2018.12.070_bib0007","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.jcv.2009.10.003","article-title":"CMV vaccine trial endpoints","volume":"46","author":"Griffiths","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0008","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0009","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MOH.0b013e328353bc7d","article-title":"Immune reconstitution after hematopoietic cell transplantation","volume":"19","author":"Bosch","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0010","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V98.5.1358","article-title":"Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection","volume":"98","author":"Gratama","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0011","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/146532402317251527","article-title":"Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide","volume":"4","author":"Einsele","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0012","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V97.5.1232","article-title":"Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation","volume":"97","author":"Cwynarski","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0013","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2005-11-012864","article-title":"Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants","volume":"108","author":"Lilleri","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0014","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood.V90.5.1751","article-title":"Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection","volume":"90","author":"Diamond","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0015","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/jis107","article-title":"Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant","volume":"205","author":"La Rosa","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0016","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2352-3026(15)00246-X","article-title":"Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial","volume":"3","author":"Nakamura","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0017","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.immunol.22.012703.104527","article-title":"Immunological memory to viral infections","volume":"22","author":"Welsh","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0018","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1182\/blood-2009-04-214684","article-title":"The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor","volume":"114","author":"Scheinberg","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0019","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1086\/591185","article-title":"Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"198","author":"Moins-Teisserenc","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0020","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.79.6.3675-3683.2005","article-title":"Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons","volume":"79","author":"Almanzar","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0021","doi-asserted-by":"crossref","first-page":"10894","DOI":"10.1128\/JVI.01477-14","article-title":"Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells","volume":"88","author":"Jackson","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0022","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1086\/590118","article-title":"Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection","volume":"198","author":"Lilleri","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0023","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0024","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/infdis\/jiw365","article-title":"A phase 1 study of 4 live, recombinant human cytomegalovirus Towne\/Toledo chimera vaccines in cytomegalovirus-seronegative men","volume":"214","author":"Adler","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/blood-2016-07-729756","article-title":"MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults","volume":"129","author":"La Rosa","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0026","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/cyto.a.20641","article-title":"Analytical performance of a standardized single-platform MHC tetramer assay for the identification and enumeration of CMV-specific CD8+ T lymphocytes","volume":"73","author":"Brooimans","year":"2008","journal-title":"Cytometry A"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0027","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2008.04.034","article-title":"A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector","volume":"377","author":"Wang","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0028","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1399-3062.2009.00489.x","article-title":"Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease","volume":"12","author":"Krishnan","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0029","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cytob.21196","article-title":"Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samples","volume":"88","author":"Tario","year":"2015","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0030","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/587749","article-title":"Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study","volume":"46","author":"Yao","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0031","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0032","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1086\/508495","article-title":"Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients","volume":"194","author":"Lacey","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0033","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/tid.12391","article-title":"Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation","volume":"17","author":"Gim\u00e9nez","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0034","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/bmt.2010.330","article-title":"Reconstitution of CMV pp65 and IE-1-specific IFN-\u03b3 CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT","volume":"46","author":"Tormo","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20420","article-title":"Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations","volume":"74","author":"Gratama","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0036","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0037","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3324\/haematol.11912","article-title":"Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection","volume":"93","author":"Lilleri","year":"2008","journal-title":"Haematologica"},{"issue":"Pt 12","key":"10.1016\/j.bbmt.2018.12.070_bib0038","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1099\/vir.0.036004-0","article-title":"Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans","volume":"92","author":"Derhovanessian","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0039","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fimmu.2017.00733","article-title":"Latent cytomegalovirus (CMV) infection does not detrimentally alter T cell responses in the healthy old, but increased latent CMV carriage is related to expanded CMV-specific T cells","volume":"8","author":"Jackson","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","article-title":"Ageing and infection","volume":"2","author":"Gavazzi","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0041","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1399-3062.2011.00626.x","article-title":"Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Borchers","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0042","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/eji.201545495","article-title":"Molecular characterization of HCMV-specific immune responses: parallels between CD8(+) T cells, CD4(+) T cells, and NK cells","volume":"45","author":"Vieira Braga","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0043","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.4049\/jimmunol.170.8.4342","article-title":"Frequencies of circulating cytolytic, CD45RA+CD27-CD8+ T lymphocytes depend on infection with CMV","volume":"170","author":"Kuijpers","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0044","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/339963","article-title":"Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype","volume":"185","author":"Khan","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0045","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1182\/blood.V97.6.1776","article-title":"Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries","volume":"97","author":"La Rosa","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0046","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/315445","article-title":"Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs","volume":"181","author":"Gyulai","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0047","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002510000271","article-title":"Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes","volume":"52","author":"Longmate","year":"2001","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0048","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood-2002-03-0926","article-title":"Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice","volume":"100","author":"La Rosa","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0049","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/523652","article-title":"Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease","volume":"197","author":"La Rosa","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0050","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0051","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4049\/jimmunol.1601992","article-title":"Characterization of high-avidity cytomegalovirus-specific T cells with differential tetramer binding coappearing after allogeneic stem cell transplantation","volume":"199","author":"Ogonek","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0052","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/sj.leu.2404681","article-title":"Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens","volume":"21","author":"Jim\u00e9nez","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0053","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1399-3062.2006.00199.x","article-title":"Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV","volume":"9","author":"Walker","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0054","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/infdis\/jix192","article-title":"Identifying cytomegalovirus complications using the quantiFERON-CMV assay after allogeneic hematopoietic stem cell transplantation","volume":"215","author":"Yong","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcv.2016.03.026","article-title":"QuantiFERON-CMV assay in allogenic stem cell transplant patients","volume":"79","author":"Bono","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0056","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","article-title":"Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities","volume":"110","author":"Wolfl","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0057","first-page":"1","article-title":"Mechanism of action of CpG DNA","volume":"247","author":"Krieg","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0058","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/01.aids.0000183514.37513.d2","article-title":"CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults","volume":"19","author":"Cooper","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0059","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1704235","article-title":"Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients","volume":"32","author":"Fallen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0060","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2010-03-273508","article-title":"Immune monitoring withiTAg MHC tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study","volume":"116","author":"Gratama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0061","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2017.00105","article-title":"\u03b3\u03b4 T cell-mediated immunity to cytomegalovirus infection","volume":"8","author":"Khairallah","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0062","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12967-016-0988-4","article-title":"Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation","volume":"14","author":"Drylewicz","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0063","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0064","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00002371-200411000-00006","article-title":"Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist","volume":"27","author":"Krieg","year":"2004","journal-title":"J Immunother"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/asheducation-2011.1.305","article-title":"Complications, diagnosis, management, and prevention of CMV infections: current and future","volume":"2011","author":"Boeckh","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0066","first-page":"291","article-title":"Letermovir treatment of human cytomegalovirus infection antiinfective agent","volume":"38","author":"Verghese","year":"2013","journal-title":"Drugs Future"},{"key":"10.1016\/j.bbmt.2018.12.070_bib0067","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118308929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118308929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:07:37Z","timestamp":1761059257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118308929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1083879118308929"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.070","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}